How much funding has CONFOMETRX, INC. raised?

CONFOMETRX, INC. has raised $33.5M in total funding, most recently a series a round.

When was CONFOMETRX, INC. founded?

CONFOMETRX, INC. was founded in 2015.

Where is CONFOMETRX, INC. headquartered?

CONFOMETRX, INC. is headquartered in PALO ALTO, California, United States.

What industry is CONFOMETRX, INC. in?

CONFOMETRX, INC. operates in Biotech, Healthcare.

CONFOMETRX, INC.

Q: Who are CONFOMETRX, INC.'s investors?

CONFOMETRX, INC.'s investors include BioGeneration Ventures, Wellington Management, Fund+, Perceptive Advisors.

Closed

Committed to Excellence in Innovation

PALO ALTO, United States · Founded 2015 · $33.5M raised

Biotech

Healthcare

Headquarters: PALO ALTO, California
Founded: 2015
Business Model: B2B
Website: confometrx.com

Total Funding: $33.5M
Last Round: $33.5M Series AJan 2024
Rounds: 1

About

ConfometRx is a pioneer in G protein-coupled receptor (GPCR) structural characterization and GPCR-targeted drug discovery, leveraging over a decade of proprietary protein engineering expertise. The company uses X-ray crystallography and cryo-EM to elucidate GPCR structures, then screens small-molecule libraries to identify therapeutic candidates for CNS, respiratory, and metabolic diseases. Co-founded by Nobel Prize laureate Dr. Brian Kobilka of Stanford University.

Summary

CONFOMETRX, INC. is a Biotech company based in PALO ALTO, United States, founded in 2015. It has raised $33.5M in total across 1 round, most recently a $33.5M Series A round in Jan 2024. Investors include BioGeneration Ventures, Wellington Management and Fund+.

LinkedIn X (Twitter)